Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer
Aditya Bardia(UCLA Health), Vered Stearns(Johns Hopkins University), Antonio C. Wolff(Johns Hopkins University), M. Dominique Ashen(Johns Hopkins University), Karineh Tarpinian(Indiana University Health), Erin T. Arieas(Johns Hopkins University), Nancy E. Davidson(WinnMed), Anne Nguyen(Indiana University School of Medicine), Jill A. Hayden(Northwestern University), Anna Maria Storniolo(Indiana University Health), N. Lynn Henry(University of Michigan), Daniel F. Hayes(University of Michigan–Ann Arbor), Pamela Ouyang(Johns Hopkins University), Roger S. Blumenthal(House of Representatives), Deborah K. Armstrong(Johns Hopkins University), Zhe Zhang(Peking University), David A. Flockhart(Indiana University – Purdue University Indianapolis), Andrew P. DeFilippis(Vanderbilt University Medical Center), Stacie C. Jeter(Johns Hopkins University), John H. Fetting(Johns Hopkins University)
Cited by 81
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
|Journal of the American College of Cardiology|2018|2.6k